The Belfast biotechnology company raised the capital from investors including Co-fund NI, QUBIS, and the Halo Business Angel Network.
"It is exciting to be able to advance the commercial development of AMPLY Discovery thanks to the tremendous support of our investors and Queen’s University Belfast. The development of initial research in this domain started out almost a decade ago when I considered adopting AI and machine learning techniques I had worked with in financial markets for the computational biology domain."
The funding was led by The Conduit Impact Fund alongside participation from SIS Ventures, Equity Gap, Old College Capital and Scottish Enterprise.
"Our process is championing the circular economy and the investment we have secured will be transformational in helping MiAlgae scale quickly both locally and abroad."
The seed round was led by Faber with participation from international venture funds to support clinical trial operations.
"For hundreds of years, treatments have been developed with the assumption they will work for everyone. However, each person is different, and for many severe diseases such as Alzheimer’s, multiple factors can contribute to the effectiveness of a treatment on a given patient."
The Stirling-based materials company will expand its production footprint and workforce after closing its latest investment.
"This investment marks a real tipping point for Integrated Graphene and the manufacturing of our unique 3D Graphene foam in its first two market-ready products. By investing now, we will be ready, this year, to produce millions of units per annum from a new facility in Stirling and to transfer the technology at scale to global partners in the future."
